132 related articles for article (PubMed ID: 21764159)
1. A meta-analysis of randomized trials for effects of atorvastatin on renal function in chronic kidney disease.
Takagi H; Umemoto T
Int J Cardiol; 2011 Oct; 152(2):242-4. PubMed ID: 21764159
[No Abstract] [Full Text] [Related]
2. Atorvastatin has no beneficial effect on cardiovascular outcomes in patients with advanced chronic kidney disease.
Kiberd BA
Nat Clin Pract Nephrol; 2006 Jul; 2(7):354-5. PubMed ID: 16932460
[No Abstract] [Full Text] [Related]
3. Effects of atorvastatin on carotid intima media thickness: a meta-analysis of randomized controlled trials.
Takagi H; Yamamoto H; Iwata K; Goto SN; Umemoto T
Int J Cardiol; 2012 Aug; 159(1):69-72. PubMed ID: 22575629
[No Abstract] [Full Text] [Related]
4. Atorvastatin (Lipitor).
Tucker G
Conn Med; 1998 May; 62(5):283-5. PubMed ID: 9639958
[No Abstract] [Full Text] [Related]
5. DUAAL: atorvastatin provided an unexpectedly potent heart benefit in patients with chronic stable angina.
Cardiovasc J Afr; 2008; 19(3):174. PubMed ID: 18568187
[No Abstract] [Full Text] [Related]
6. Benefits of atorvastatin in cholesterol lowering.
Farmer JA
Curr Atheroscler Rep; 2003 Mar; 5(2):94-5. PubMed ID: 12573192
[No Abstract] [Full Text] [Related]
7. Intensive lipid lowering with atorvastatin in patients with coronary heart disease and chronic kidney disease: the TNT (Treating to New Targets) study.
Shepherd J; Kastelein JJ; Bittner V; Deedwania P; Breazna A; Dobson S; Wilson DJ; Zuckerman A; Wenger NK;
J Am Coll Cardiol; 2008 Apr; 51(15):1448-54. PubMed ID: 18402899
[TBL] [Abstract][Full Text] [Related]
8. [AVERT [The Atorvastatin versus Revascularization Treatment]].
Mokuno H
Nihon Rinsho; 2001 Mar; 59 Suppl 3():436-41. PubMed ID: 11347110
[No Abstract] [Full Text] [Related]
9. HMG-CoA reductase inhibitors and renal function.
Campese VM; Park J
Clin J Am Soc Nephrol; 2007 Nov; 2(6):1100-3. PubMed ID: 17942762
[No Abstract] [Full Text] [Related]
10. A controlled, prospective study of the effects of atorvastatin on proteinuria and progression of kidney disease.
Bianchi S; Bigazzi R; Caiazza A; Campese VM
Am J Kidney Dis; 2003 Mar; 41(3):565-70. PubMed ID: 12612979
[TBL] [Abstract][Full Text] [Related]
11. Atorvastatin preserves renal function in chronic complete unilateral ureteral obstruction.
Michli E; Gulmi FA; Chou SY; Mooppan UM; Kim H
J Urol; 2007 Feb; 177(2):781-5. PubMed ID: 17222681
[TBL] [Abstract][Full Text] [Related]
12. Effect of intensive lipid lowering with atorvastatin on renal function in patients with coronary heart disease: the Treating to New Targets (TNT) study.
Shepherd J; Kastelein JJ; Bittner V; Deedwania P; Breazna A; Dobson S; Wilson DJ; Zuckerman A; Wenger NK;
Clin J Am Soc Nephrol; 2007 Nov; 2(6):1131-9. PubMed ID: 17942759
[TBL] [Abstract][Full Text] [Related]
13. [To lessen the cardiovascular risk of the diabetic patient. Atorvastatin of use for diabetic patients without coronary disease, too].
MMW Fortschr Med; 2005 Aug; 147(33-34):51. PubMed ID: 16138641
[No Abstract] [Full Text] [Related]
14. [Atorvastatin].
Kajinami K; Takekoshi N
Nihon Rinsho; 2001 Mar; 59 Suppl 3():598-604. PubMed ID: 11347138
[No Abstract] [Full Text] [Related]
15. Effects of atorvastatin on kidney outcomes and cardiovascular disease in patients with diabetes: an analysis from the Collaborative Atorvastatin Diabetes Study (CARDS).
Colhoun HM; Betteridge DJ; Durrington PN; Hitman GA; Neil HA; Livingstone SJ; Charlton-Menys V; DeMicco DA; Fuller JH;
Am J Kidney Dis; 2009 Nov; 54(5):810-9. PubMed ID: 19540640
[TBL] [Abstract][Full Text] [Related]
16. Comparison of benefits and risks of rosuvastatin versus atorvastatin from a meta-analysis of head-to-head randomized controlled trials.
Wlodarczyk J; Sullivan D; Smith M
Am J Cardiol; 2008 Dec; 102(12):1654-62. PubMed ID: 19064019
[TBL] [Abstract][Full Text] [Related]
17. Atorvastatin improves tubular status in non-diabetic patients with chronic kidney disease - placebo controlled, randomized, cross-over study.
Renke M; Tylicki L; Rutkowski P; Neuwelt A; Larczyński W; Ziętkiewicz M; Aleksandrowicz E; Lysiak-Szydłowska W; Rutkowski B
Acta Biochim Pol; 2010; 57(4):547-52. PubMed ID: 21079818
[TBL] [Abstract][Full Text] [Related]
18. Indications for coronary artery bypass surgery and percutaneous coronary intervention in chronic stable angina: review of the evidence and methodological considerations.
Rihal CS; Raco DL; Gersh BJ; Yusuf S
Circulation; 2003 Nov; 108(20):2439-45. PubMed ID: 14623791
[No Abstract] [Full Text] [Related]
19. Focused atorvastatin therapy in managed-care patients with coronary heart disease and CKD.
Koren MJ; Davidson MH; Wilson DJ; Fayyad RS; Zuckerman A; Reed DP;
Am J Kidney Dis; 2009 May; 53(5):741-50. PubMed ID: 19216014
[TBL] [Abstract][Full Text] [Related]
20. Atorvastatin ameliorates tubulointerstitial fibrosis and protects renal function in chronic partial ureteral obstruction cases.
Fitzgerald JP; Chou SY; Franco I; Mooppan UM; Kim H; Saini R; Gulmi FA
J Urol; 2009 Oct; 182(4 Suppl):1860-8. PubMed ID: 19692013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
